ArticleAmerican journal of nuclear medicine and molecular imaging2019

Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.

Jadith Ziegler et al.PubMed ↗Full text ↗

No numbers read from the abstract.